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The apoptotic index, cell cycle progression and caspase-3 activation in k-562 cells induced to differen-
tiate by DMSo or quercetin have been studied. Quercetin treatment of k-562 cells was accompanied by cell 
cycle arrest in G2 /M and apoptosis with caspase-3 activation. In contrast, DMSo-induced differentiation was 
accompanied by the complete cell cycle arrest in G1 /G0 with negligible caspase-3 activation. In spite of the ap-
pearance of benzidine-positive cells and the decreased cD71 level in k-562 cells after exposure to quercetin, 
the analysis of 1h NMR spectra revealed the overall balance in favor of apoptosis, namely the increase in the 
content of NMR-visible mobile lipid domains and the decreased intensity of choline-containing metabolites. 
k e y  w o r d s: apoptosis, caspase-3, cell cycle, chronic myelogenous leukemia, DMSo, flavonoids, 
mobile lipid domains, quercetin. 
The induction of leukemic cell differentia-tion may provide an alternative approach to the conventional cytotoxic chemotherapy 
of leukemia [1]. Nevertheless, the application of 
differentiation therapy in leukemia patients is cur-
rently limited only to several forms of leukemias. 
Meanwhile, the precise mechanisms of pharmaco-
logically induced differentiation of leukemic cells 
and their relations to apoptotic cell pathways are 
not well understood.
Quercetin (3,3′,4′,5,7-pentahydroxy flavone), 
which is one of the most widely distributed fla-
vonoids in nature, has been reported to possess 
antiproliferative and proapoptotic activities in 
leukemic cells [2–4]. These activities do not seem 
to be related only to the conventional antioxidant 
properties of this substance. Several mechanisms 
of the apoptogenic effects of quercetin have been 
suggested, with death receptor-5, anti-apoptotic 
Bcl-2 and Bcl-xL proteins, caspases, Akt/PKB 
kinase, Cu-Zn superoxide dismutase, fatty acid 
synthase and heat shock proteins being among the 
cellular targets [5–7]. Few reports have shown that 
quercetin may also induce differentiation in hu-
man chronic myelogenous leukemia [8, 9]. Quer-
cetin was also shown to induce apoptosis in K562 
and several other human leukemic cell lines [10]. 
Nevertheless, the relations between apoptosis and 
differentiations in quercetin-treated cells as well as 
the mechanisms of quercetin-triggered differentia-
tion have not been studied in detail. 
Abundant experimental evidence has demon-
strated that besides their role in the initiation and 
execution of apoptosis, caspases have been also 
involved in such physiological processes as cell 
survival, proliferation, differentiation, and inflam-
mation [11, 12]. Several data suggest the roles of 
caspases in erythroid differentiation in the bone 
marrow [13, 14]. 
The dual effect of quercetin as well as some 
other flavonoids inducing both apoptosis and cell 
differentiation makes it rather difficult to analyze 
these effects separately in cell populations. The use 
of the approaches allowing one to assess the overall 
effects may be advantageous for characterizing the 
balance of these two processes in cell populations. 
While 1H NMR has been shown to detect the apop-
totic changes in cell membranes by the shifts in 
the content of NMR-visible mobile lipid domains 
and choline-containing metabolite intensity [15], 
the changes in 1H NMR detectable parameters in 
the systems of cell differentiation have not yet been 
followed. 
Therefore, the major objective of the study 
was to compare the apoptosis induction, cell cyc-
le progression and caspase-3 activation in K-562 
cells induced to differentiate by dimethyl sulfoxide 
(DMSO) or quercetin. We also have attempted to 
analyze the patterns of 1H NMR spectra, namely 
the content of NMR-visible mobile lipid domains 
and choline-containing metabolite intensity in 
cells undergoing apoptosis or differentiation with 
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the aim of assessing the overall balance of apopto-
sis and differentiation in K-562 cells treated with 
quercetin. 
materials and methods
Chemicals. Quercetin purchased from Sigma 
Chem. Co. (USA) was dissolved in 96% ethanol 
and further diluted in culture medium. Vepeside 
was purchased from Brystol-Myers Squibb SpA 
(Italy).
Cell culture and treatment. Human K-562 
cell line was obtained from the National Collec-
tion of Cell Lines of the Institute of Experimen-
tal Pathology, Oncology and Radiobiology (Kyiv, 
Ukraine). Quercetin or DMSO was added to the 
cells at the beginning of the exponential growth 
phase. Cell growth and viability were assessed by 
direct counting of trypan blue dye-excluding cells. 
The percentage of hemoglobin-producing cells was 
determined by a benzidine staining method as pre-
viously described [16]. 
Proton NMR-spectroscopy. The high-reso-
lution 1H NMR spectra were acquired using a 
300 MHz Varian Mercury 300BB NMR spectrome-
ter (Varian, USA). The details of the technique 
were described [17]. The areas of signals at 0.9 and 
1.3 ppm arising from –CH3 and (–CH2–)n groups 
of fatty acyl chains of lipids as well as signals at 
3.2 ppm arising from choline-containing metabo-
lites (Cho), which include choline and phospho-
rylcholine, were integrated using VNMR software 
(Varian, USA) and expressed in relative units.
Flow cytometric analysis. A) cell cycle distri-
bution and apoptosis. The cells were resuspended in 
hypotonic buffer containing 0.1% sodium citrate, 
0.1% Triton X-100, 5 μg/ml propidium iodide. 
250 μg/ml of RNAse A was added to each sample, 
and the cells were stained for 15 min at 37 °C. 
Flow cytometry was performed on a FACScan 
automated system (Becton Dickinson, USA), and 
data were analyzed using CellQuest software packa-
ge and ModFit LT 2.0 program. 
B) Immunostaining. The percentage of cells 
with active form of caspase-3 was assessed using 
FITC-conjugated MAb active caspase-3 kit (BD 
Biosciences, USA) according to the manufacturer’s 
recommendations. Expression of CD71 on the sur-
face of K-562 cells was evaluated by flow cytomet-
ry as described previously [18].
Statistical analysis. Each experiment was rep-
licated three times. The results of the experimental 
and control groups were tested for statistical sig-
nificance by a one-tailed Student’s t test.
results and discussion
First, the effects of quercetin and DMSO 
on cell growth, cell cycle and differentiation were 
compared. K-562 cells were treated with quercetin 
at concentrations up to 40 μM or 1.9% DMSO. 
Quercetin slightly inhibited cell proliferation, 
while DMSO suppressed completely cell growth 
without increasing cell death. In cells treated with 
quercetin, the increase in hypodiploid cell frac-
tion up to 15% was evident. Meanwhile, the cells 
grown in the presence of DMSO have shown no 
increase in apoptotic cell fraction (Fig. 1, A). As 
shown in Fig. 1, B, quercetin treatment for 48 h re-
sulted in relatively moderate increase (about 25%) 
in the percentage of cells with the active form of 
caspase-3. In contrast, DMSO treatment has not 
induced caspase-3 activation relative to baseline 
level. In addition, the opposite effects of quercetin 
and DMSO on cell cycle traverse have been shown. 
Namely, DMSO induced complete arrest in G0/G1 
phase, while quercetin suppressed the growth of K-
562 cells by blocking the cell cycle predominantly 
in G2 /M phase (Fig. 2). 
In contrast to DMSO-induced differentia-
tion of K-562 cells involving practically the whole 
cell population, morphological and cytochemical 
analysis of quercetin-treated cells reveal only par-
tial features of erythroid differentiation in 15–20% 
of cells. Nevertheless, the differentiation effect of 
quercetin was confirmed by the increasing percenta-
ge of hemoglobin-containing (benzidine-positive) 
cells (38 ± 4% over the baseline level 16 ± 2%). 
We next investigated the expression of cell sur-
face transferrin receptor (CD71) as a non-lineage 
specific marker of early erythroid progenitor cells 
in the course of DMSO- or quercetin-induced dif-
ferentiation of K-562 cells. CD71 is known to be 
lost as these cells differentiate to mature eryth-
rocytes. Flow cytometric analysis demonstrated 
strong decrease in the percentage of CD71-positive 
cells upon DMSO treatment: in 72 h transferrin 
receptor was practically undetectable (Fig. 3). In 
quercetin-treated cells, slight reduction of the per-
centage of CD71-positive cells was observed (75% 
at 48 h as compared with the basal level). The 
differences between DMSO and quercetin treat-
ments in CD71 are quite in line with morphologi-
cal changes and assessment of benzidine-positive 
cells – therefore indicating only partial differen-
tiation within cell population and in a different cell 
cycle setting.
Since the findings above suggest that the 
differentiation of K562 cells induced by querce-
tin but not DMSO is accompanied by apoptosis, 
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it would be of interest to assess the overall balan-
ce of differentiation and apoptosis in this system 
by 1H NMR analysis. Some representative spec-
tra given in Fig. 4 showed 1.6-fold decrease of the 
CH2/CH3 signal intensity ratio corresponding to 
MLD content and 2.4-fold increase of the inten-
sity of Cho resonance in K-562 cells treated with 
DMSO. In contrast, the CH2/CH3 signal intensity 
ratio in the same cells treated with vepeside as a 
typical apoptosis inducer increased about two-fold, 
while the intensity of Cho resonance was thrice as 
low as that in untreated cells. The analysis of 1H 
NMR spectra in K-562 cells exposed to quercetin 
revealed the overall balance of changes in favor of 
apoptosis, namely the 1.6-fold increase in MLD 
content and 1.8-fold decrease in Cho resonance 
intensity as compared to the control values.
The human K562 cell line has been used 
widely as a valuable model for erythroid differen-
tiation in vitro which is induced by various substan-
ces. The intrinsic commitment of at least part of 
K562 cell population to differentiate has been also 
Fig. 1. Induction of apoptosis (A) and activation of caspase-3 (B) in k-562 cells treated with quercetin or 
DMSo. a – control; b – 40 μM quercetin, 48 h; c – 1.9% DMSo, 48 h. The figures show a representative 
staining profile for 10,000 cells per experiment. M1 is the cell population defined as apoptotic (A) or caspase-
3-positive (B)
Fig. 1. Induction of apoptosis (A) and activation of caspase-3 (B) in K-562 cells treated with 
quercetin or DMSO. Each experiment was done in triplicate. a – control; b – 40 PM quercetin, 
48 h; c – 1.9% DMSO, 48 h. The figures show a representative staining profile for 10,000 cells 
per experim nt. M1 is the cell population defined as apoptotic (A) or casp e-3-positive (B). 
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Fig. 2. cell cycle analysis of k-562 cells after 48 h treatment with quercetin or DMSo: a – control; b – 40 μM 
quercetin; c – 1.9% DMSo. cells were stained with PI for flow cytometry analysis and DNA histograms were 
plotted with ModFit software
Treatment
Cell cycle phase distribution in %
G0 /G1 S G2 /M
Control 37.92 ± 0.87 57.78 ± 0.41 4.29 ± 0.29
Quercetin 40 μM 15.48 ± 0.73 60.30 ± 0.54 24.22 ± 0.25
DMSO 1.9% 77.24 ± 0.26 15.04 ± 0.39 7.73 ± 0.95
Fig. 2. Cell cycle analysis of K-562 cells after 48 h treatment with quercetin or DMSO. a – 
control; b – 40 PM quercetin; c – 1.9% DMSO. Cells were stained with PI for flow cytometry 
analysis and DNA histograms were modeled with ModFit software. 
Cell cycle phase distribution in %  Treatment 
G0/G1 S G2/M
Control 37.92 ± 0.87 57.78 ± 0.41 4.29 ± 0.29 
Quercetin 40 PM 15.48 ± 0.73 60.30 ± 0.54 24.22 ± 0.25 
DMSO 1.9% 77.24 ± 0.26 15.04 ± 0.39 7.73 ± 0.95 
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Fig. 3. cell surface transferrin receptor expression in k-562 cells treated with 1.9% DMSo (A) or 40 μM 
quercetin (B): a – control; b – 48 h; c – 72 h. Black peaks (d) show negative control (anti-transferrin receptor 
antibody is omitted). The figures show a representative staining profile for 10,000 cells per experiment. The log 
fluorescence intensity is shown on the horizontal axis. on the vertical axis the cell number is plotted
Fig. 3. Cell surface transferrin receptor expression in K-562 cells treated with 1.9% DMSO (A) 
or 40 PM quercetin (B). a – control; b – 48 h; c – 72 h. Black peaks (d) show negative control 
(anti-transferrin receptor antibody is omitted). The figures show a representative staining profile 
for 10,000 cells per experiment. The log fluorescence intensity is shown on the horizontal axis. 
On the vertical axis the cell number is plotted. 
Fig. 3. Cell surface transferrin recept r expression in K-562 cells treated with 1.9% DMSO (A) 
or 40 PM quercetin (B). a – control; b – 48 h; c – 72 h. Black peaks (d) show negative control 
(anti-transferrin receptor antibody is omitted). The figures show  represe tative staining profile 
for 10,000 cells p r experiment. Th  log fluor scence intensity is shown on the horizontal axis. 
On the vertical axis the cell number is plotted. 
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demonstrated [19]. Molecular mechanisms of such 
differentiation induced by unrelated agents and 
their relevance to the normal process of erythroid 
differentiation have been still far from being elu-
cidated. The existence of various regulatory path-
ways involved in the final differentiation effects 
has not been excluded. Among the agents capable 
of inducing the differentiation of K562 cells are 
cytotoxic chemotherapeutics drugs as well, which 
induce differentiation at the subtoxic doses [20]. 
Therefore, the relation between the differentiation 
and the involvement of the apoptothic pathway 
mechanisms is still to be investigated. Nevertheless, 
several authors believe that apoptosis and erythroid 
differentiation of chronic myelogenous leukemia 
cells represent the different processes, which may 
be easily dissociated [21]. Although some inves-
tigators suggested that quercetin can trigger dif-
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Fig. 4. Representative high-resolution 300 Mhz spectra of k-562 cells. 1 – cells treated with DMSo (1.9%, 
18 h); 2 – control; 3 – cells treated with quercetin (40 μM, 48 h); 4 – cells treated with vepeside (20 μM, 
18 h)
ferentiation in K-562 cells [8, 9], this could not be 
confirmed by others [22]. Furthermore, in some 
cases quercetin was shown to inhibit the environ-
mental stress-induced differentiation of K-562 cells 
[23].
Our studies demonstrated some features of 
erythroid differentiation of K562 cells induced by 
quercetin. In particular, the exposure to quercetin 
resulted in the increase of benzidine-positive cell 
count in K-562 culture over the baseline level. 
Treatment of those cells with either DMSO or 
quercetin downregulated cell surface transferrin 
receptors, which may be important in causing 
cessation of transferrin-mediated iron transport 
required for cell growth. 
Nevertheless, the features of differentiation 
of K562 cells induced by quercetin are distinct 
from DMSO-induced differentiation. The most 
important is that quercetin-induced differentiation 
is accompanied by caspase-3 activation and 
apoptosis in a fraction of cell population. This result 
is in agreement with the data obtained in human 
acute myelogenous or promyelocytic leukemia cells 
treated with flavonoids [4, 24]. In contrast, DMSO-
induced differentiation was not accompanied by 
Fig. 4. Representative high-resolution 300 MHz spectra of K-562 cells. 1 – cells treated with 
DMSO (1.9%, 18 h); 2 – control; 3 – cells treated with quercetin (40 PM, 48 h); 4 – cells treated 
with vepeside (20 PM, 18 h).
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caspase-3 activation suggesting that at least in this 
system caspase-3 is not involved in differentiation 
pathways. While quercetin-treated K-562 cells are 
arrested in G2/M transition phase, DMSO blocked 
cell cycle progression in G0 /G1 phase. However, it 
is not possible to demonstrate whether caspase-3 
activation in quercetin-treated cells is associated 
with the fraction of cells undergoing differentiation 
or apoptosis. 
It is known that flavonoids may induce both 
apoptosis and differentiation in leukemic cells [25]. 
Therefore, we have attempted to assess the overall 
balance of apoptosis and differentiation in cell 
population with the aid of 1H NMR-spectroscopy. 
An increased 1H NMR-visible MLD formation 
has been reported as a peculiar feature of cells 
undergoing apoptosis or proliferating cells [15]. 
Earlier, we have observed MLD accumulation and 
Cho decrease in apoptotic malignant lymphoid cells 
upon quercetin treatment [17]. In the present study, 
the opposite spectral changes in cells undergoing 
erythroid differentiation were identified. Namely, 
DMSO-induced differentiation in K-562 cells was 
accompanied by the decrease of the CH2/CH3 signal 
intensity ratio and the marked increase of Cho 
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resonance intensity being evident as early as 18 h 
after the onset of differentiation. These data are in 
line with those of Agris and Campbell [26] who 
found a dramatic increase of a signal at 3.2 ppm 
in Friend leukemia cells induced to differentiate 
by DMSO. Furthermore, it was proposed that 
an increased phosphorylcholine level might be a 
marker of differentiation in diverse cell systems 
(see in [27]). According to our data, the decrease 
in 1H NMR-visible MLD formation may be 
regarded as one of the features characteristic of the 
increased differentiation status of the cells, at least 
in the system of DMSO-induced differentiation in 
K-562 cells. As to quercetin treatment of K-562 
cells, the data on MLD content suggest the overall 
shift towards apoptosis. 
To sum up, our results demonstrated that 
quercetin in contrast to DMSO induced both apop-
tosis and erythroid differentiation in K-562 cells 
with the apoptotic trend in the overall effects. The 
potential role of the apoptotic effectors in the con-
trol of cell differentiation merits further investiga-
tion using other differentiating agents.
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апоптоз та вміст мобільних 
ліпідних доменів в клітинах 
к-562 лейкемії людини при 
їхньому диференціюванні, 
індукованому кверцетином 
або диметилсульфоксидом
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Визначали апоптотичний індекс, прохо-
дження клітинного циклу та активацію каспа-
зи-3 в клітинах K-562 в разі диференціювання, 
індукованого кверцетином або диметилсуль-
фоксидом (ДМСО). Обробка клітин кверцети-
ном супроводжувалась зупинкою клітинного 
циклу в фазі G2/M та призводила до апоптозу і 
активації каспази-3. Навпаки, в разі диферен-
ціювання, індукованого ДМСО, спостерігали 
повну зупинку клітинного циклу у фазі G1/G0 
без активації каспази-3. Незважаючи на поя-
ву бензидин-позитивних клітин та зниження 
вмісту CD71 після інкубації з кверцетином, 
аналіз спектрів 1H ЯМР виявив баланс змін у 
бік апоптозу, а саме збільшення вмісту ЯМР-
візуалізованих мобільних ліпідних доменів та 
зниження інтенсивності сигналу холін-вміс-
них метаболітів.
К л ю ч о в і  с л о в а: апоптоз, каспаза-3, 
клітинний цикл, хронічна мієлоїдна лейкемія, 
ДМСО, флавоноїди, мобільні ліпідні домени, 
кверцетин.
апоптоз и содержание 
мобильных липидных 
доменов в клетках к-562 
лейкоза человека при их 
дифференцировке, 
индуцированной кверцетином 
или диметилсульфоксидом
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Определяли апоптотический индекс, 
прохождение клеточного цикла и активацию 
каспазы-3 в клетках K-562 при индукции диф-
ференцировки кверцетином или диметилсуль-
фоксидом (ДМСО). Обработка клеток кверце-
тином сопровождалась остановкой клеточного 
цикла в фазе G2 /M и активацией каспазы-3. 
В противоположность этому при дифферен-
цировке, индуцированной ДМСО, отмечали 
полную остановку клеточного цикла в фазе 
G1 /G0 без активации каспазы-3. Несмотря на 
появление бензидин-положительных клеток и 
снижение содержания CD71 после инкубации 
с кверцетином, анализ спектров 1H ЯМР вы-
явил баланс изменений в сторону апоптоза, а 
именно, увеличение содержания ЯМР-визуа-
лизируемых мобильных липидных доменов и 
снижение интенсивности сигнала холин-со-
держащих метаболитов.
К л ю ч е в ы е  с л о в а: апоптоз, каспаза-3, 
клеточный цикл, хронический миелолейкоз, 
ДМСО, флавоноиды, мобильные липидные 
домены, кверцетин.
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